CURLF
Curaleaf Holdings

8,694
Mkt Cap
$1.47B
Volume
1.04M
52W High
$3.65
52W Low
$0.675
PE Ratio
-5.49
CURLF Fundamentals
Price
$1.95
Prev Close
$1.91
Open
$1.90
50D MA
$2.76
Beta
1.00
Avg. Volume
681,936.87
EPS (Annual)
-$0.3215
P/B
1.80
Loading...
Loading...
News
all
press releases
Cresco Labs Expands Operations Beyond U.S.: How to Play the Stock?
CRLBF's move into Germany opens a new growth path as it navigates U.S. pricing pressure and rising competition in its core market.
Zacks·1d ago
News Placeholder
More News
News Placeholder
Should You Buy, Hold or Sell CGC Stock Post Q2 Earnings Release?
Canopy Growth's narrower loss, rising Canadian sales and improving margins signal progress in its turnaround, even as competition and global headwinds persist.
Zacks·7d ago
News Placeholder
Tilray Brands Extends Global Reach With Key Approvals and Launches
TLRY expands its global medical cannabis footprint with key launches and approvals across Panama, Germany, Italy and Australia.
Zacks·10d ago
News Placeholder
Cannabis Stock Tilray Brands Skyrockets 94.5%: Time to Buy, Sell or Hold?
TLRY's 94.5% surge, record fiscal Q1 revenues, and expanding medical cannabis footprint fuel optimism amid global challenges.
Zacks·13d ago
News Placeholder
Curaleaf Holdings, Inc. (CURLF) Reports Q3 Loss, Beats Revenue Estimates
Curaleaf Holdings, Inc. (CURLF) delivered earnings and revenue surprises of +14.29% and +1.04%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·15d ago
News Placeholder
Can TerrAscend Deliver a Solid Q3 on Core Market Strength Ahead?
TSNDF's Q3 results are likely to benefit from Northeast market strength, margin gains, and a streamlined focus following its Michigan exit.
Zacks·17d ago
News Placeholder
Cannabis Stock VFF Soars Over 300% YTD: Time to Buy, Sell or Hold?
Village Farms' surge reflects its pivot to a pure-play cannabis model, record profitability and a confident $10M share buyback.
Zacks·24d ago
News Placeholder
How to Play Aurora Cannabis Stock Amid Renewed Legalization Hopes?
Aurora Cannabis gains 21% as its medical segment fuels revenue and margin growth, even as recreational sales drag.
Zacks·29d ago
News Placeholder
Should You Buy TLRY Stock After Encouraging Q1 Results?
Tilray's return to profitability, stronger cash flow, and expanding global cannabis and beverage operations highlight its renewed growth story.
Zacks·1mo ago
News Placeholder
Should You Buy or Sell CURLF Stock Amid Renewed Legalization Hopes?
Curaleaf's shares have soared over 200% on renewed legalization optimism, but domestic weakness and profit hurdles cloud the outlook.
Zacks·1mo ago

Latest CURLF News

View

Advertisement|Remove ads.

Advertisement|Remove ads.